Trials / Completed
CompletedNCT06592950
Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 513 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this research is to assess T2DM patient preferences for a once weekly insulin treatment. The study involves a qualitative interview phase and quantitative survey phase with a Discrete Choice Experiment (DCE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | Online survey |
| OTHER | No treatment given | Interviews |
Timeline
- Start date
- 2023-11-02
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06592950. Inclusion in this directory is not an endorsement.